- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01105923
Study of an Intervention to Improve Problem List Accuracy and Use (MAPLE)
Making Accurate Problem Lists in the EHR
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The clinical problem list is a cornerstone of the problem-oriented medical record. Problem lists are used in a variety of ways throughout the process of clinical care. In addition to its use by clinicians, the problem list is also critical for decision support and quality measurement.
Patients with gaps in their problem list face significant risks. For example, if a hypothetical patient has diabetes properly documented, his clinician would receive appropriate alerts and reminders to guide care. Additionally, the patient might be included in special care management programs and the quality of care provided to him would be measured and tracked. Without diabetes on his problem list, he might receive none of these benefits.
In this study, the investigators developed an clinical decision support intervention that will identify patients with problem lists gaps. The investigators will alert providers of these likely gaps and offer providers the opportunity to correct them.
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02115
- Brigham and Women's Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Independent healthcare provider (physician, NP, PA)
- Practices at participating site
Exclusion Criteria:
- None
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Diagnostisk
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Receive CDS intervention
Providers in clinics that will receive the CDS alert, as their clinic was randomized into our study.
|
MAPLE is a CDS intervention within the EHR that will alert providers to problem lists gaps and present an opportunity to correct them.
|
|
Ingen indgriben: No CDS intervention
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Intervention acceptance
Tidsramme: 6 months (May 2010-Nov2010)
|
Of those providers who were shown (or who would have been shown, for the control group) the intervention, the number that added a problem across control and intervention groups.
|
6 months (May 2010-Nov2010)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Problem list prevalence
Tidsramme: pre and post intervention
|
Number of patients with selected problems on their problem list pre and post intervention across intervention and control groups.
|
pre and post intervention
|
|
Problem list incidence
Tidsramme: pre and post intervention
|
For the conditions of interest, the percent of patients that had the problem added during the study period
|
pre and post intervention
|
|
Quality improvement based on problem list accuracy/completion
Tidsramme: post intervention
|
For those with problems added due to the intervention, the number of new triggered reminders or other clinical actions.
|
post intervention
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Adam Wright, PhD, Brigham and Women's Hospital
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Psykiske lidelser
- Myokardieiskæmi
- Hjertesygdomme
- Hjerte-kar-sygdomme
- Karsygdomme
- Metaboliske sygdomme
- Sygdomme i nervesystemet
- Sygdomme i immunsystemet
- Åreforkalkning
- Arterielle okklusive sygdomme
- Neoplasmer
- Autoimmune sygdomme i nervesystemet
- Autoimmune sygdomme
- Neoplasmer efter sted
- Nyresygdomme
- Urologiske sygdomme
- Sygdomme i det endokrine system
- Hæmatologiske sygdomme
- Genetiske sygdomme, medfødte
- Muskuloskeletale sygdomme
- Skjoldbruskkirtelsygdomme
- Neuromuskulære sygdomme
- Neurodegenerative sygdomme
- Anæmi
- Neoplasmer i nervesystemet
- Koronar sygdom
- Knoglesygdomme
- Opmærksomhedsunderskud og forstyrrende adfærdsforstyrrelser
- Neuroudviklingsforstyrrelser
- Paraneoplastiske syndromer, nervesystemet
- Paraneoplastiske syndromer
- Neuromuskulære Junction-sygdomme
- Anæmi, hæmolytisk, medfødt
- Anæmi, hæmolytisk
- Hæmoglobinopatier
- Hjertefejl
- Koronararteriesygdom
- Hypothyroidisme
- Nyreinsufficiens
- Hyperthyroidisme
- Attention Deficit Disorder med hyperaktivitet
- Osteoporose
- Myasthenia gravis
- Anæmi, seglcelle
- Knoglesygdomme, metaboliske
Andre undersøgelses-id-numre
- 2009P001846
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .